Bristol-Myers Squibb Delivers Excellent First Quarter with YERVOY™ (ipilimumab) Approval
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Genzyme Revenues Grow in First-Quarter 2011
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
Shire delivers a strong first quarter performance
- Details
- Category: Shire
![Shire Shire](/images/stories/logo/shire.gif)
Lilly and Medtronic Announce Drug-Device Collaboration for Parkinson's Disease
- Details
- Category: Eli Lilly and Company
![Lilly Lilly](/images/stories/logo/lilly.gif)
Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Bayer affirms the positive benefit-risk profile of its drospirenone- containing oral contraceptives
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Lundbeck's partner Mochida receives approval of Lexapro in Japan
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
More Pharma News ...
- Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
- Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
- Abbott Reports 17.4 Percent Sales Growth
- Novartis makes strong start for the year
- GSK welcomes key agreement to support global preparedness against pandemic influenza
- Roche Group's first-quarter 2011 sales on track for full-year targets
- Pfizer Announces Top-Line Results of Third Phase 3 Clinical Trial of Tofacitinib (CP-690,550)